Pundir · Journal of minimally invasive gynecology 2017 · systematic review and meta-analysis · n=3 studies (335 participants)

Laparoscopic Excision Versus Ablation for Endometriosis-associated Pain: An Updated Systematic Review and Meta-analysis.

Cited 88 times in the scientific literature.

Level 1 - systematic review of randomized trials

Systematic review and meta-analysis of randomized controlled trials

PubMed 28456617 · doi:10.1016/j.jmig.2017.04.008 · record verified 2026-08-26

What was done

Authors conducted a systematic review and meta-analysis across multiple databases (including MEDLINE, Embase, Cochrane Library, and trial registries) comparing laparoscopic excision versus laparoscopic ablation for endometriosis-associated pain. Three randomized controlled trials were included, enrolling 335 total participants (sample sizes per study ranging from 24 to 178). Data from 2 studies were pooled for meta-analysis. The primary outcome was visual analog scale (VAS) score reduction for dysmenorrhea; secondary outcomes included VAS changes for dyspareunia, dyschezia, chronic pelvic pain, and Endometriosis Health Profile-30 (EHP-30) core pain scores.

What was found

Pooled meta-analysis showed excision led to a significantly greater reduction in dysmenorrhea (mean difference [MD] = 0.99; 95% CI, -0.02 to 2.00; p = .05) and dyschezia (MD = 1.31; 95% CI, 0.33 to 2.29; p = .009) compared with ablation. Dyspareunia improvement showed a nonsignificant difference (MD = 0.96; 95% CI, -0.07 to 1.99; p = .07). Data from one study showed significant reductions favoring excision for chronic pelvic pain (MD = 2.57; 95% CI, 1.27 to 3.87; p = .0001) and EHP-30 scores (MD = 13.20; 95% CI, 3.70 to 22.70; p = .006).

Why it matters

Laparoscopic excision provides modest pain advantages over ablation for dysmenorrhea, dyschezia, and pelvic pain at 12 months postsurgery. This provides surgical guidance, though the small volume of trial data warrants cautious interpretation.

Limits

The total evidence base is small, comprising only 3 trials with 335 participants, and only 2 studies could be quantitatively pooled. The confidence interval for the primary outcome of dysmenorrhea spanned zero despite a reported p-value of .05. Secondary outcomes like chronic pelvic pain and quality-of-life scores were derived from a single study. Adverse events, complications, reoperation rates, and outcomes beyond 12 months were not reported in the abstract.

Cited by